Frank Takkinen
Stock Analyst at Lake Street
(0.63)
# 3,680
Out of 5,082 analysts
703
Total ratings
36.6%
Success rate
-1.6%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COCH Envoy Medical | Reiterated: Buy | $2.5 → $25 | $6.51 | +284.02% | 19 | Oct 27, 2026 | |
| AXGN Axogen | Reiterated: Buy | $55 | $37.46 | +46.82% | 16 | Oct 5, 2026 | |
| ELUT Elutia | Reiterated: Buy | $5 | $0.8048 | +521.27% | 34 | Oct 5, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | $7 | $3.90 | +79.49% | 11 | Oct 1, 2026 | |
| CLPT ClearPoint Neuro | Reiterated: Buy | $25 | $9.69 | +158.00% | 52 | Sep 30, 2026 | |
| TELA TELA Bio | Reiterated: Buy | $2 | $0.96 | +108.33% | 43 | Sep 30, 2026 | |
| HYPR Hyperfine | Reiterated: Buy | $2.5 | $0.7497 | +233.47% | 21 | Sep 28, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $50 | $19.22 | +160.15% | 6 | Sep 28, 2026 | |
| TLSI TriSalus Life Sciences | Reiterated: Buy | $8 | $3.80 | +110.53% | 23 | Sep 23, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $25 | $21.39 | +16.88% | 15 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3.5 | $1.42 | +147.35% | 48 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.455 | +779.12% | 17 | Sep 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.21 | +352.49% | 1 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $12 | $16.08 | -25.37% | 14 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $32.84 | +6.58% | 4 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.94 | +118.86% | 19 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $9.03 | +32.89% | 28 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $15 | $11.93 | +25.73% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $1.03 | +191.26% | 39 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $22.94 | +96.16% | 37 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.17 | +152.37% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $83.95 | +42.94% | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.98 | +102.02% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $13.02 | +53.61% | 49 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $12.26 | +95.76% | 5 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $8.89 | +158.72% | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.10 | +3,900.00% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $135 | $83.79 | +61.12% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $6.00 | +150.00% | 9 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $71.30 | n/a | 28 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $2.50 | n/a | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.12 | n/a | 11 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.14 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.43 → $19.63 | $7.88 | n/a | 9 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $40 | $0.000001 | n/a | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $12 | $0.055 | n/a | 3 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $1.19 | n/a | 4 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $10 | $4.16 | n/a | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.61 | $0.16 | n/a | 1 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $10 | $0.0003 | n/a | 3 | Mar 31, 2022 |
Envoy Medical
Oct 27, 2026
Reiterated: Buy
Price Target: $2.5 → $25
Current: $6.51
Upside: +284.02%
Axogen
Oct 5, 2026
Reiterated: Buy
Price Target: $55
Current: $37.46
Upside: +46.82%
Elutia
Oct 5, 2026
Reiterated: Buy
Price Target: $5
Current: $0.8048
Upside: +521.27%
MiMedx Group
Oct 1, 2026
Reiterated: Buy
Price Target: $7
Current: $3.90
Upside: +79.49%
ClearPoint Neuro
Sep 30, 2026
Reiterated: Buy
Price Target: $25
Current: $9.69
Upside: +158.00%
TELA Bio
Sep 30, 2026
Reiterated: Buy
Price Target: $2
Current: $0.96
Upside: +108.33%
Hyperfine
Sep 28, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.7497
Upside: +233.47%
Tandem Diabetes Care
Sep 28, 2026
Reiterated: Buy
Price Target: $50
Current: $19.22
Upside: +160.15%
TriSalus Life Sciences
Sep 23, 2026
Reiterated: Buy
Price Target: $8
Current: $3.80
Upside: +110.53%
Beta Bionics
Sep 22, 2026
Reiterated: Buy
Price Target: $25
Current: $21.39
Upside: +16.88%
Sep 22, 2026
Reiterated: Hold
Price Target: $3.5
Current: $1.42
Upside: +147.35%
Sep 22, 2026
Reiterated: Buy
Price Target: $4
Current: $0.455
Upside: +779.12%
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.21
Upside: +352.49%
Aug 28, 2026
Reiterated: Buy
Price Target: $8 → $12
Current: $16.08
Upside: -25.37%
Aug 26, 2026
Reiterated: Hold
Price Target: $35
Current: $32.84
Upside: +6.58%
Aug 25, 2026
Reiterated: Buy
Price Target: $13
Current: $5.94
Upside: +118.86%
Aug 19, 2026
Reiterated: Buy
Price Target: $12
Current: $9.03
Upside: +32.89%
Aug 14, 2026
Rated: Buy
Price Target: $21 → $15
Current: $11.93
Upside: +25.73%
Aug 12, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.03
Upside: +191.26%
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $22.94
Upside: +96.16%
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $3.17
Upside: +152.37%
Aug 3, 2026
Reiterated: Buy
Price Target: $120
Current: $83.95
Upside: +42.94%
Jul 30, 2026
Reiterated: Buy
Price Target: $4
Current: $1.98
Upside: +102.02%
Jul 29, 2026
Reiterated: Buy
Price Target: $20
Current: $13.02
Upside: +53.61%
Jul 14, 2026
Reiterated: Buy
Price Target: $24
Current: $12.26
Upside: +95.76%
May 26, 2026
Reiterated: Buy
Price Target: $23
Current: $8.89
Upside: +158.72%
May 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.10
Upside: +3,900.00%
May 6, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $83.79
Upside: +61.12%
Jan 23, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $6.00
Upside: +150.00%
Aug 27, 2025
Reiterated: Buy
Price Target: $150
Current: $71.30
Upside: n/a
Aug 9, 2024
Reiterated: Buy
Price Target: $2.5
Current: $2.50
Upside: n/a
Jul 22, 2024
Reiterated: Buy
Price Target: $10
Current: $4.12
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $4
Current: $2.14
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $22.43 → $19.63
Current: $7.88
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $150 → $40
Current: $0.000001
Upside: n/a
Feb 14, 2023
Reiterated: Buy
Price Target: $4 → $12
Current: $0.055
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $1
Current: $1.19
Upside: n/a
May 11, 2022
Reiterated: Buy
Price Target: $14 → $10
Current: $4.16
Upside: n/a
Apr 5, 2022
Initiated Coverage: Buy
Price Target: $5.61
Current: $0.16
Upside: n/a
Mar 31, 2022
Downgraded: Hold
Price Target: $6 → $10
Current: $0.0003
Upside: n/a